glp 1 for diabetes type 2 GLP-1 drugs are all approved glucose control in (T2D). Some of them also have additional indications reflecting their demonstrated benefits for cardiovascular disease, kidney health, and obesity. None GLP-1 Receptor Agonists | Incretin

Spot treatment with concentrated copper peptide products directly on deep wrinkles, as recommended by some protocols, may deliver better results than general facial application alone

Transfusional iron overload and intravenous iron infusions modify the mouse gut microbiota similarly to dietary iron

Overeating processed meats, skipping omega-3-rich fish, or ignoring micronutrient needs can tip the scale toward more inflammation, not less

RSC Adv (2025) 13(40):2823049

Blue Cross Blue Shield of Massachusetts (BCBSMA) will stop covering every GLP-1 written for obesity on January 1, 2026, unless an employer pays extra for a rider